4
Changes in Ownership
KYNTRA BIO, INC. Filed Acc 0001209191-23-036080
Director sold 4,733 shares at an average $17.19 ($81,367)
- Director acquired 8,289 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Brennan Aoife · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-06-07 | Grant or award : show line 1 in the form 10b5-1 | +8,289 | 32,680 | D | ||
| 2023-06-09 | Sale : show line 2 in the form 10b5-1 | −1,994 | $16.74 | $33,380 | 30,686 | D |
| 2023-06-09 | Sale : show line 3 in the form 10b5-1 | −2,739 | $17.52 | $47,987 | 27,947 | D |
| Open-market sales · 4,733 sh · avg $17.19 · $81,367 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-06-07 | Grant or award : show line 4 in the form 10b5-1 Stock Option (Right to Buy) | +12,666 | 12,666 | D |
Loading xslF345X04/doc4.xml…